IRIS
PATRIARCA, ANDREA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.945
EU - Europa 1.707
AS - Asia 1.260
SA - Sud America 153
Continente sconosciuto - Info sul continente non disponibili 82
AF - Africa 45
OC - Oceania 9
Totale 5.201
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.846
SG - Singapore 486
RU - Federazione Russa 476
IT - Italia 394
IE - Irlanda 260
CN - Cina 203
VN - Vietnam 169
HK - Hong Kong 148
DE - Germania 145
SE - Svezia 121
BR - Brasile 109
FR - Francia 76
BD - Bangladesh 69
GB - Regno Unito 57
IN - India 54
CA - Canada 53
FI - Finlandia 50
UA - Ucraina 30
KR - Corea 24
ID - Indonesia 20
MX - Messico 20
TR - Turchia 18
BJ - Benin 17
PL - Polonia 16
AR - Argentina 14
NL - Olanda 14
ES - Italia 13
ZA - Sudafrica 12
CZ - Repubblica Ceca 11
LT - Lituania 11
AU - Australia 9
IR - Iran 9
JP - Giappone 9
PK - Pakistan 9
AT - Austria 7
CO - Colombia 7
CR - Costa Rica 7
SA - Arabia Saudita 7
CL - Cile 6
EC - Ecuador 6
IQ - Iraq 5
JM - Giamaica 5
EE - Estonia 4
EG - Egitto 4
JO - Giordania 4
VE - Venezuela 4
AE - Emirati Arabi Uniti 3
AZ - Azerbaigian 3
BE - Belgio 3
DZ - Algeria 3
ET - Etiopia 3
GP - Guadalupe 3
MA - Marocco 3
MY - Malesia 3
NI - Nicaragua 3
PE - Perù 3
PH - Filippine 3
PY - Paraguay 3
RS - Serbia 3
TH - Thailandia 3
UZ - Uzbekistan 3
BG - Bulgaria 2
CW - ???statistics.table.value.countryCode.CW??? 2
DK - Danimarca 2
HN - Honduras 2
KZ - Kazakistan 2
LV - Lettonia 2
MD - Moldavia 2
PR - Porto Rico 2
SY - Repubblica araba siriana 2
AL - Albania 1
AO - Angola 1
BO - Bolivia 1
CH - Svizzera 1
DM - Dominica 1
GE - Georgia 1
GT - Guatemala 1
HT - Haiti 1
HU - Ungheria 1
KE - Kenya 1
LU - Lussemburgo 1
MK - Macedonia 1
NG - Nigeria 1
NO - Norvegia 1
OM - Oman 1
PT - Portogallo 1
RO - Romania 1
TT - Trinidad e Tobago 1
TW - Taiwan 1
YE - Yemen 1
Totale 5.121
Salva come PNG Salva come JPEG
Città #
San Jose 258
Dublin 253
Ashburn 151
Hong Kong 148
Singapore 139
Council Bluffs 120
Piemonte 70
Los Angeles 68
Chandler 66
Columbus 60
Novara 60
Beijing 59
New York 44
Phoenix 44
Ho Chi Minh City 43
Moscow 42
Munich 42
Helsinki 40
Lauterbourg 39
Hanoi 36
Jacksonville 34
Orem 30
Santa Clara 29
Boardman 25
Lawrence 25
Princeton 25
Toronto 24
Buffalo 23
Bremen 21
Seoul 21
São Paulo 19
Chennai 18
Frankfurt am Main 18
Milan 18
Cotonou 17
Dallas 17
Chicago 16
San Mateo 16
Turin 16
Brooklyn 15
Falkenstein 14
Genoa 14
Montreal 14
Wilmington 14
Atlanta 13
Grafing 13
Haiphong 13
London 13
Rome 13
Houston 12
Guangzhou 11
Jakarta 11
St Louis 11
Warsaw 11
Denver 10
Mexico City 10
Nuremberg 10
Strasbourg 10
Turku 10
Brno 9
Poplar 9
Boston 8
Dong Ket 8
Redondo Beach 8
San Bernardino 8
Stockholm 8
Sydney 8
Amsterdam 7
Andover 7
Da Nang 7
Johannesburg 7
Olathe 7
Tokyo 7
Assago 6
Bologna 6
Naples 6
San José 6
Shanghai 6
Ankara 5
Bexley 5
Charlotte 5
Milwaukee 5
Mumbai 5
New Delhi 5
San Francisco 5
Vercelli 5
West Jordan 5
Charleston 4
Dalian 4
Hefei 4
Islamabad 4
Istanbul 4
Kingston 4
Miami 4
Pittsburgh 4
Quito 4
Riyadh 4
Santiago 4
Schaumburg 4
Tianjin 4
Totale 2.671
Salva come PNG Salva come JPEG
Nome #
Comparative Analysis of the Performance of Automated Digital Cell Morphology Analyzers for Leukocyte Differentiation in Hematologic Malignancies: Mindray MC‐80 Versus West Medical Vision Hema 262
A randomized clinical study on the impact of Comprehensive Geriatric Assessment (CGA) based interventions on the quality of life of elderly, frail, onco-hematologic patients candidate to anticancer therapy: protocol of the ONCO-Aging study 247
SARS-CoV-2 omicron (B.1.1.529)-related COVID-19 sequelae in vaccinated and unvaccinated patients with cancer: results from the OnCovid registry 192
Time-Dependent COVID-19 Mortality in Patients with Cancer: An Updated Analysis of the OnCovid Registry 154
Targeting p53 in chronic lymphocytic leukemia 152
COVID-19 Sequelae and the Host Proinflammatory Response: An Analysis From the OnCovid Registry 148
Biological and clinical implications of BIRC3 mutations in chronic lymphocytic leukemia 146
Patterns of neutralizing humoral response to SARS-CoV-2 infection among hematologic malignancy patients reveal a robust immune response in anti-cancer therapy-naive patients 144
Systemic pro-inflammatory response identifies patients with cancer with adverse outcomes from SARS-CoV-2 infection: The OnCovid Inflammatory Score 143
Genetic predisposition to myelodysplastic syndromes: A challenge for adult hematologists 141
Vaccination against SARS-CoV-2 protects from morbidity, mortality and sequelae from COVID19 in patients with cancer 136
Multiregional sequencing and circulating tumour DNA analysis provide complementary approaches for comprehensive disease profiling of small lymphocytic lymphoma 135
Presenting features and early mortality from SARS-CoV-2 infection in cancer patients during the initial stage of the COVID-19 pandemic in Europe 133
Clinical portrait of the SARS-CoV-2 epidemic in European cancer patients 131
An update on: molecular genetics of high-risk chronic lymphocytic leukemia 129
Atypical chronic myeloid leukemia: Where are we now? 128
Induction of robust humoral immunity against SARS-CoV-2 after vaccine administration in previously infected haematological cancer patients 127
Precision medicine management of chronic lymphocytic leukemia 125
Lymphocyte doubling time in chronic lymphocytic leukemia modern era: a real-life study in 848 unselected patients 124
Stiffer Spleen Predicts Higher Bone Marrow Fibrosis and Higher JAK2 Allele Burden in Patients With Myeloproliferative Neoplasms 123
A phase 3 study of pelebresib plus ruxolitinib for JAK inhibitor-naive patients with myelofibrosis 121
A Rare Case of Life-Threatening Jaundice Caused by Epstein-Barr Virus Infection and Secondary Cold Agglutinin Syndrome Successfully Treated with Rituximab 120
Immune checkpoint inhibitor therapy and outcomes from SARS-CoV-2 infection in patients with cancer: a joint analysis of OnCovid and ESMO-CoCARE registries 119
Determinants of enhanced vulnerability to coronavirus disease 2019 in UK patients with cancer: a European study 119
Higher-order connections between stereotyped subsets: implications for improved patient classification in CLL 116
Eltrombopag second-line therapy in adult patients with primary immune thrombocytopenia in an attempt to achieve sustained remission off-treatment: results of a phase II, multicentre, prospective study 113
High reproducibility of spleen stiffness measurement by vibration-controlled transient elastography with a spleen-dedicated module 113
A step ahead toward precision medicine for chronic lymphocytic leukemia 110
Precision Medicine in Systemic Mastocytosis 110
An acquired factor V inhibitor induced uncontrolled bleeding in a postsurgery patient 109
Venetoclax with Hypomethylating Agents in Newly Diagnosed Acute Myeloid Leukemia: A Systematic Review and Meta-Analysis of Survival Data from Real-World Studies 108
High BECN1 Expression Negatively Correlates with BCL2 Expression and Predicts Better Prognosis in Diffuse Large B-Cell Lymphoma: Role of Autophagy 108
The Biology of Chronic Lymphocytic Leukemia: Diagnostic and Prognostic Implications 100
Outcomes of the SARS-CoV-2 omicron (B.1.1.529) variant outbreak among vaccinated and unvaccinated patients with cancer in Europe: results from the retrospective, multicentre, OnCovid registry study 100
Ponatinib for the treatment of Ph-like acute lymphoblastic leukemia 99
Prescription patterns of venetoclax in acute myeloid leukemia 93
Cerebrospinal fluid xanthochromia after pegasparaginase hepatotoxicity in B-cell acute lymphoblastic leukemia 91
Innovative Use of Fostamatinib in Managing Refractory Immune Thrombocytopenia in an HIV ‐Positive Patient: A Case Report 68
Investigational drugs for the treatment of diffuse large B-cell lymphoma 62
Intravascular lymphoma: from vessels to genes 60
Real‐world efficacy and safety of fostamatinib in ITP patients: Italian multicentre experience. GIMEMA ITP1122 study 51
Diagnostic Challenges in a Young Man with a Suspected Mast Cell Disorder, Dysplastic Bone Marrow Morphology, and a ZRSR2 Mutation 48
Liquid biopsy in lymphomas: a potential tool for refining diagnosis and disease monitoring 23
Assessing prognosis of chronic lymphocytic leukemia using biomarkers and genetics 20
Totale 5.201
Salva come PNG Salva come JPEG
Categoria #
all - tutte 25.047
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 25.047
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022242 0 0 0 34 18 10 23 13 13 36 50 45
2022/2023543 46 22 47 4 35 47 25 20 250 3 25 19
2023/2024269 27 23 23 7 38 9 36 6 4 5 37 54
2024/2025824 21 19 43 10 28 30 47 138 124 51 113 200
2025/20262.451 116 76 121 273 263 164 371 409 187 214 131 126
2026/2027679 104 201 199 175 0 0 0 0 0 0 0 0
Totale 5.201